Investing Profile

Lorence Kim

InvestorVC

Co-founder and Managing Partner at Ascenta Capital

thirdrockventures.com/people/...Cambridge, Massachusetts

Your Intro Paths to Lorence Kim

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Lorence is a member of

Goldman Sachs Network

1032 CONNECTIONS

Harvard University Network

898 CONNECTIONS

Harvard University Network

898 CONNECTIONS

The Wharton School Network

832 CONNECTIONS

University of Pennsylvania - The Wharton School Network

287 CONNECTIONS

Find Lorence Kim on

Current Investing Position

Ascenta Capital Managing Partner

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

Lorence Kim is on these Sector & Stage Rankings

BioTech (Series B)Pharmaceuticals (Seed)BioTech (Seed)Pharmaceuticals (Series B)Pharmaceuticals (Series A)BioTech (Series A)New York City Boston / New England

Lorence Kim's Investments On Record (4)

Company	StageDateRound Size	Total Raised
Triana Biomedicines	Series BDec 2025$120M	$230M
Co-investors: Andrew Hedin (Bessemer Venture Partners), Christopher O'Donnell (Pfizer Ventures), David Grayzel (Atlas Venture)
Tubulis	Series COct 2025$400M	$620M
Co-investors: John de Koning (LSP), Sofia Ioannidou (Andera Partners), Sebastian Pünzeler (Apollo Health Ventures), Patrick Heron (Frazier Healthcare Partners), Nimish Shah (Venrock)
Odyssey Therapeutics	Series CDec 2023$100M	$700M
Co-investors: Elena Viboch (General Catalyst), Carl Gordon (OrbiMed Advisors), Jill carroll (S.R. One Ltd), Brenton Fargnoli (Kamanu Ventures & Lightspeed Venture Partners Scout), Nan Li (6 Dimensions Capital), Ravi Mhatre (Kamanu Ventures & Lightspeed Venture Partners Scout), Jonathan MacQuitty (Kamanu Ventures & Lightspeed Venture Partners Scout)
ADARx Pharmaceuticals	Series CAug 2023$200M Series BJan 2023$46M	$320M
Co-investors: Simeon J. George (SR One), Carl Gordon (OrbiMed Advisors)

Lorence Kim's Experience

Co-founder and Managing Partner Ascenta Capital2023 - Present

Board Member AmerisourceBergen2022 - Present

Board Member REVOLUTION Medicines2022 - Present

Chief Financial Officer Moderna TherapeuticsPresent

Independent Board Member Cowen Inc.Present

Independent Board Member REVOLUTION MedicinesPresent

Independent Board Member CencoraPresent

Chief Financial Officer Commonwealth Fusion SystemsPresent

Co-founder and Advisory Partner Ascenta CapitalPresent

Co-founder and Board Member ElevAAte BiotechPresent

Board Member Flare Therapeutics2021 - 2025

Board Member Abata Therapeutics2021 - 2025

Board Member Cowen Inc.2022 - 2023

Venture Partner Third Rock Ventures2020 - 2022

Board Member Seres Therapeutics2014 - 2020

Chief Financial Officer Moderna2014 - 2020

Managing Director Goldman Sachs2000 - 2014

Lorence Kim's Education

University of Pennsylvania - The Wharton School MBA Healthcare Management

University of Pennsylvania School of Medicine Doctor of Medicine (MD)

Harvard University AB, magna cum laude Biochemical Sciences

Harvard University AB magna cum laude, Biochemical Sciences

International General Certificate of Secondary Education (IGCSE) MBA Healthcare Management

The Wharton School MBA Healthcare Management

Investors who invest with Lorence Kim

Scouts & Angels Affiliated With Lorence Kim